Press Releases Year None202220212020201920182017 January 10, 2022 IN8bio to Present at Upcoming January Investor Conferences Read More PDF Version January 6, 2022 IN8bio Announces Clinical Updates from the Phase 1 Clinical Trial of its Genetically Modified Gamma-Delta T Cell Therapy in Newly Diagnosed Glioblastoma Multiforme Read More PDF Version
January 6, 2022 IN8bio Announces Clinical Updates from the Phase 1 Clinical Trial of its Genetically Modified Gamma-Delta T Cell Therapy in Newly Diagnosed Glioblastoma Multiforme Read More PDF Version
